Literature DB >> 28867159

New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.

David Taïeb1, Karel Pacak2.   

Abstract

Pheochromocytomas and paragangliomas (PPGLs) belong to the family of neural crest cell-derived neoplasms. In up to 70% of cases they are associated with germline and somatic mutations in 15 well-characterized PPGL driver or fusion genes. PPGLs can be grouped into three main clusters, where cluster 1 includes PPGLs characterized by a pseudohypoxic signature. Although cluster 1 tumors share several common features, they exhibit unique behaviors. We present here unique insights into the imaging phenotypes of cluster 1 PPGLs based on glucose uptake, catecholamine metabolism, and somatostatin receptor expression. Recent data suggest that succinate is a major player in the imaging phenotype of succinate dehydrogenase-deficient PPGLs. This review emphasizes the emerging stromal cell-succinate interaction and highlights new perspectives in PPGL theranostics.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (68)Ga-DOTATATE; 6-[(18)F]-fluoro-L-3,4-dihydroxyphenylalanine; gallium radioisotopes; magnetic resonance; paraganglioma; pheochromocytoma; positron emission tomography; radionuclide therapy; somatostatin; theranostics

Mesh:

Substances:

Year:  2017        PMID: 28867159      PMCID: PMC5673583          DOI: 10.1016/j.tem.2017.08.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  80 in total

1.  Cancer. Puzzling patterns of predisposition.

Authors:  Patrick J Pollard; Peter J Ratcliffe
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

2.  The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

Authors:  Tobias Else; Monica L Marvin; Jessica N Everett; Stephen B Gruber; H Alexander Arts; Elena M Stoffel; Richard J Auchus; Victoria M Raymond
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

3.  Identification of cysteine residues in human cationic amino acid transporter hCAT-2A that are targets for inhibition by N-ethylmaleimide.

Authors:  Sarah R Beyer; Robert T Mallmann; Isabel Jaenecke; Alice Habermeier; Jean-Paul Boissel; Ellen I Closs
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

Review 4.  Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.

Authors:  Aurélie Morin; Eric Letouzé; Anne-Paule Gimenez-Roqueplo; Judith Favier
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

5.  Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.

Authors:  Elena López-Jiménez; Gonzalo Gómez-López; L Javier Leandro-García; Iván Muñoz; Francesca Schiavi; Cristina Montero-Conde; Aguirre A de Cubas; Ricardo Ramires; Iñigo Landa; Susanna Leskelä; Agnieszka Maliszewska; Lucía Inglada-Pérez; Leticia de la Vega; Cristina Rodríguez-Antona; Rocío Letón; Carmen Bernal; José M de Campos; Cristina Diez-Tascón; Mario F Fraga; Cesar Boullosa; David G Pisano; Giuseppe Opocher; Mercedes Robledo; Alberto Cascón
Journal:  Mol Endocrinol       Date:  2010-10-27

Review 6.  Rethinking pheochromocytomas and paragangliomas from a genomic perspective.

Authors:  L J Castro-Vega; C Lepoutre-Lussey; A-P Gimenez-Roqueplo; J Favier
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 7.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

8.  In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Bellucci; Aurélie Morin; Alexandre Buffet; Laurence Amar; Maxime Janin; Chris Ottolenghi; Franck Zinzindohoué; Gwennhael Autret; Nelly Burnichon; Estelle Robidel; Benjamin Banting; Sébastien Fontaine; Charles-André Cuenod; Paule Benit; Pierre Rustin; Philippe Halimi; Laure Fournier; Anne-Paule Gimenez-Roqueplo; Judith Favier; Bertrand Tavitian
Journal:  Clin Cancer Res       Date:  2015-10-21       Impact factor: 12.531

9.  Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis.

Authors:  Robert D Guzy; Bhumika Sharma; Eric Bell; Navdeep S Chandel; Paul T Schumacker
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

10.  68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.

Authors:  Ingo Janssen; Clara C Chen; David Taieb; Nicholas J Patronas; Corina M Millo; Karen T Adams; Joan Nambuba; Peter Herscovitch; Samira M Sadowski; Antonio T Fojo; Inga Buchmann; Electron Kebebew; Karel Pacak
Journal:  J Nucl Med       Date:  2015-11-12       Impact factor: 10.057

View more
  17 in total

1.  Molecular Imaging in the Era of Precision Medicine: Paraganglioma as a Template for Understanding Multiple Levels of Analysis.

Authors:  David Taïeb; Dimitris Visvikis; Rodney J Hicks; Karel Pacak
Journal:  J Nucl Med       Date:  2020-03-13       Impact factor: 10.057

2.  Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A 18 F-FDOPA PET/CT study.

Authors:  Vincent Amodru; Pauline Romanet; Ugo Scemama; Marion Montava; Nicolas Fakhry; Frédéric Sebag; Frédéric Castinetti; Jean-Pierre Lavieille; Anderson Loundou; Arthur Varoquaux; Anne Barlier; Karel Pacak; David Taïeb
Journal:  Head Neck       Date:  2018-12-24       Impact factor: 3.147

Review 3.  Prognostic and predictive value of nuclear imaging in endocrine oncology.

Authors:  Giorgio Treglia; Bernard Goichot; Luca Giovanella; Elif Hindié; Abhishek Jha; Karel Pacak; David Taïeb; Thomas Walter; Alessio Imperiale
Journal:  Endocrine       Date:  2019-11-16       Impact factor: 3.633

4.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

5.  Genetic stratification of inherited and sporadic phaeochromocytoma and paraganglioma: implications for precision medicine.

Authors:  Ruth Casey; Hartmut P H Neumann; Eamonn R Maher
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 6.  Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects.

Authors:  David Taïeb; Henri Timmers; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-04-04       Impact factor: 2.936

7.  Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.

Authors:  Zahraa Abdul Sater; Abhishek Jha; Ahmed Hamimi; Adel Mandl; Iris R Hartley; Sriram Gubbi; Mayank Patel; Melissa Gonzales; David Taïeb; Ali Cahid Civelek; Ahmed M Gharib; Sungyoung Auh; Alana E O'Mara; Karel Pacak; Aaron M Cypess
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

8.  Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A 18 F-FDOPA PET/CT study in head and neck paragangliomas.

Authors:  Thibaut Reichert; Nicolas Fakhry; Jean-Pierre Lavieille; Vincent Amodru; Frédéric Sebag; Pauline Romanet; Anderson Loundou; Frédéric Castinetti; Karel Pacak; Marion Montava; David Taïeb
Journal:  Clin Endocrinol (Oxf)       Date:  2019-10-01       Impact factor: 3.523

9.  Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma.

Authors:  Miguel-Angel Díaz-Castellanos; Karina Villar Gómez de Las Heras; Tamara Díaz-Redondo; Encarnación González-Flores; Virginia Albiñana; Luisa-María Botella
Journal:  F1000Res       Date:  2017-12-04

10.  Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.

Authors:  Abhishek Jha; Kristine de Luna; Charlene Ann Balili; Corina Millo; Cecilia Angela Paraiso; Alexander Ling; Melissa K Gonzales; Bruna Viana; Rami Alrezk; Karen T Adams; Isabel Tena; Alice Chen; Jiri Neuzil; Margarita Raygada; Electron Kebebew; David Taieb; M Sue O'Dorisio; Thomas O'Dorisio; Ali Cahid Civelek; Constantine A Stratakis; Leilani Mercado-Asis; Karel Pacak
Journal:  Front Oncol       Date:  2019-02-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.